Procyrion, Inc.

Procyrion, Inc. is a medical device company specializing in the development of minimally invasive percutaneous mechanical circulatory support (pMCS) devices for heart failure patients. Their flagship product, Aortix™, is a small, catheter-deployed pump designed to reduce the workload on the heart and improve blood flow to vital organs. Aortix™ aims to address the unmet needs of patients suffering from cardiorenal syndrome, a condition characterized by heart failure and worsening kidney function, which often leads to high mortality and re-admission rates.

Procyrion's team comprises experienced life science entrepreneurs, engineers, cardiologists, and heart failure specialists. Their dedication to innovation has garnered recognition, including the Fierce15 Medtech of 2023 award and significant funding, totaling $57.7 million in Series E financing. The company is currently in the research and development phase and is focused on conducting clinical trials for Aortix™, with the ultimate goal of bringing this groundbreaking technology to market and improving the lives of heart failure patients.

Procyrion does not mention any specific job flexibility options on their website or in their job postings.

Procyrion, Inc. is a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment by developing safe and innovative percutaneous mechanical circulatory support (pMCS) devices. Their primary focus is on addressing the unmet clinical needs of heart failure patients through the development of their Aortix™ device, a minimally invasive pump designed to rest the heart and support the kidneys by accelerating blood flow in the aorta.

Procyrion cultivates a collaborative and innovative culture, bringing together experienced life science entrepreneurs, engineers, cardiologists, and heart failure specialists to develop groundbreaking medical devices. The company values a team-oriented approach, where diverse expertise is leveraged to address the unmet needs of heart failure patients. This dedication to improving patient outcomes is evident in their commitment to research and development, as well as their strong commitment to fostering a positive and supportive work environment.

Procyrion actively fosters a diverse and inclusive workplace, recognizing the value of varied perspectives and backgrounds in its mission to improve the lives of heart failure patients. The company actively seeks out and hires individuals from diverse backgrounds, including those with diverse ethnicities, genders, and lived experiences. This commitment to diversity is reflected in its leadership team, which includes experts from various fields, and its Scientific Advisory Board, composed of leading cardiologists and cardiovascular researchers from diverse backgrounds.